Reimbursed Care Access in Nicaragua

Currently classified as a strictly controlled substance under Nicaragua’s national drug‑control framework (Law No. 177 as amended by Law No. 285), with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The general narcotics/psychotropic law (Law No. 177/Amendment 285) governs MDMA as a proscribed psychotropic. #

Esketamine (Spravato) is not recorded as an authorized marketed antidepressant product in Nicaragua, and there is no public documentation of a national regulatory approval or public reimbursement pathway. Nicaragua’s national medicines/registration mechanisms are administered by the MINSA Pharmacy Directorate; novel psychiatric products like intranasal esketamine would require explicit product registration and import authorization from MINSA before clinical or commercial use, and no such registration appears in publicly available MINSA registries. For context, Nicaragua’s controlled‑substance and pharmaceutical import rules are implemented by MINSA’s Dirección de Farmacia and the Dirección General de Regulación Sanitaria. # #

Ketamine is a controlled psychotropic substance in Nicaragua but is permitted and managed for legitimate medical uses (principally as an anesthetic) under MINSA regulation. Nicaragua’s national essential medicines/peti torio lists include ketamine among general anesthetics, and importation/marketing of ketamine products is subject to import permits and quota controls administered by the MINSA Pharmacy Directorate (Dirección de Farmacia). Operationally, ketamine is available within the health system for anesthesia and emergency medicine; however, reimbursement and coverage are limited to established indications (anesthesia/analgesia) within public and private healthcare procurement — there is no evidence of nationwide public reimbursement or formal approval for novel psychiatric indications such as intravenous ketamine for depression. See MINSA essential medicines list (ketamina listed under anesthetics) and WTO notification describing import/control requirements for ketamine. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Nicaragua’s general controlled‑substance law covers synthetic and natural psychotropics under a regulated schedule. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The national narcotics/psychotropics legislation (Law No. 285) is the operative legal framework. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public record of regulatory authorization or recognized clinical programs for ibogaine in Nicaragua. #

Although ayahuasca is a plant‑based traditional preparation, the active constituents (DMT and related tryptamines) fall under Nicaragua’s controlled substance framework; therefore, ayahuasca use, possession or distribution is regulated and unauthorized use is treated as a controlled‑substance offense outside of approved research or explicitly authorized religious exemptions (none publicly documented). Currently classified as a strictly controlled substance under national drug scheduling laws. #

Mescaline and mescaline‑containing cacti (e.g., peyote) are treated under the national controlled‑substance framework; there is no public legal exemption or regulated medical use recorded for mescaline in Nicaragua. Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. #

Synthetic phenethylamines in the 2C family are covered by Nicaragua’s psychotropic substances law and treated as controlled substances; there is no authorized medical use outside of approved clinical research. Currently classified as a strictly controlled substance under national drug scheduling laws. #